Foghorn Therapeutics (FHTX) Non-Current Assets (2019 - 2026)

Foghorn Therapeutics' Non-Current Assets history runs 8 years deep, the most recent figure standing at $34.1 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 2.49% year-over-year to $34.1 million; the TTM figure through Mar 2026 stood at $112.2 million (down 21.95% YoY), while the FY2025 annual figure was $34.9 million, up 1.42% from the prior year.
• Non-Current Assets for Q1 2026 stood at $34.1 million, down from $34.9 million in the prior quarter.
• The five-year high for Non-Current Assets was $58.5 million in Q1 2022, with the low at $20.8 million in Q3 2025.
• The 5-year median for Non-Current Assets is $43.5 million (2024), against an average of $42.3 million.
• The sharpest annual moves came in 2025 and 2026: Non-Current Assets sank 43.87% in 2025, then climbed 2.49% in 2026.
• Foghorn Therapeutics' Non-Current Assets stood at $53.5 million in 2022, then dropped by 14.49% to $45.7 million in 2023, then dropped by 24.83% to $34.4 million in 2024, then rose by 1.42% to $34.9 million in 2025, then declined by 2.19% to $34.1 million in 2026.
• Business Quant data shows FHTX's Non-Current Assets at $34.1 million in Q1 2026, $34.9 million in Q4 2025, and $20.8 million in Q3 2025.